Search
site map
IP Handbook Blog
Your source for expert commentary on IP management issues.
Go to the blog
About
MIHR
PIPRA
Fiocruz, Brazil
bioDevelopments- Institute
|
HARNER-JAY, Claudia
Claudia Harner-Jay is a program officer with PATH’s Technology Solutions Strategic Program. Her major responsibilities include creating and implementing commercialization strategies for health technologies; managing intellectual property issues; identifying potential partners and performing due diligence; and negotiating collaboration agreements. She also serves as team leader or project manager for select health technology initiatives. While at PATH, Ms. Harner-Jay has managed numerous market research studies to help refine product development activities, identify potential partners, and inform introduction strategies. Before joining PATH, Ms. Harner-Jay was a business development manager at Monsanto Life Sciences Company and helped develop the market for agricultural products produced by small farmers in low-resource settings in Latin America. In addition, she has worked with coffee farmers in Central America, where her findings and recommendations led to a US$50 million World Bank loan for the coffee industry in El Salvador. Ms. Harner-Jay also worked for UBS in Zurich, where she earned a Swiss Banking Diploma. She holds an M.B.A. and an M.S. in environmental policy from the University of Michigan and a B.A. in international affairs from the University of Puget Sound. She is fluent in both Spanish and German.
Abstract
How Public–Private Partnerships Handle Intellectual Property: The PATH Experience
Abstract:
PATH is an international, nonprofit organization that creates sustainable, culturally relevant solutions, enabling communities worldwide to break longstanding cycles of poor health. By collaborating with diverse public and private sector partners, PATH helps provide appropriate health technologies and vital strategies that change the way people think and act. PATH’s work improves global health and well-being. Over the past 28 years, PATH has demonstrated that public–private partnerships (PPPs) can effectively address unmet public health needs, particularly when managed with a clear understanding of both public and private sector objectives. Indeed, collaboration between public sector and private sector partners is an especially valuable way to develop and advance appropriate health technologies for use in developing countries. When developing and managing PPPs, PATH recognizes that intellectual property (IP) is an especially important component in the range of variables that affect the economic, technical, and programmatic feasibility of a new health technology intervention. Our goal, therefore, is to incorporate IP considerations as a fundamental part of the PPP process. We seek to manage IP strategically to avoid or quickly overcome any IP-related roadblocks. Using three case studies, this chapter illustrates PATH’s strategies for private sector collaboration, as well as PATH’s approaches to managing IP.
|